Abstract:Abstract Background Bone mesenchymal stem cells (BMSCs)-derived exosomes (B-exos) are attractive for applications in enabling alloantigen tolerance. An in-depth mechanistic understanding of the interaction between B-exos and dendritic cells (DCs) could lead to novel cell-based therapies for allogeneic transplantation. Herein, the potential of a B-exos-based application combined with DCs was explored for inducing allogeneic transplant tolerance. Methods After mixed culture of BMSCs and DCs for 48 hours, DCs from the upper layer were collected to analyze the expression levels of surface markers and mRNAs of inflammation-related cytokines. Then the DCs were co-cultured with B-exo before being collected to detect the mRNA and protein expression levels of indoleamine 2,3-dioxygenase (IDO). The treated DCs from different groups were co-cultured with naïve CD4 + T cells from the mouse spleen. The proliferation of CD4 + T cells and the proportion of CD4 + CD25 + Foxp3 + T cells were analyzed. Finally, the skins of BALB/c mice were transplanted to the back of C57 mice to establish a mouse allogeneic skin transplantation model. Results The coculture of DCs with BMSCs in a trans-well system downregulated the expression of the major histocompatibility complex class II (MHC-II) and CD80/86 costimulatory molecules on DCs, as well as the mRNA expression of interleukin-10 ( IL-10 ), IL-12 , and transforming growth factor-β ( TGF-β ). However, these findings were abolished when treated with GW4869. Moreover, B-exos (5 μg/mL) increased the expression of indoleamine 2,3-dioxygenase (IDO) in DCs treated with lipopolysaccharide (LPS) compared to the control cells. CD4 + CD25 + Foxp3 + T cells increased when cultured with B-exos-exposed DCs, which was attenuated by 1-methyl tryptophan (1MT). Mice recipients injected with B-exos-treated DCs significantly prolonged the skin allograft survival. The allografts showed slight cell infiltration and significantly preserved graft structure. Also, the level of CD4 + CD25 + Foxp3 + T cells was significantly higher in B-exos-exposed DCs recipient animals than that in other groups. Conclusions Taken together, these data suggested that the B-exos suppress the maturation of DCs and increase the expression of IDO, which might shed light on the role of B-exos in inducing alloantigen tolerance.

Murine Bone Marrow Mesenchymal Stem Cells Cause Mature Dendritic Cells to Promote T‐Cell Tolerance

Polarization of T Lymphocytes is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB/c Mice

Bone marrow mesenchymal stem cell-derived exosomes attenuate the maturation of dendritic cells and reduce the rejection of allogeneic transplantation.

[The Effect of Murine Mesenchymal Stem Cells on the Differentiation and Function of Allogenetic Bone Marrow-Derived Dendritic Cells.].

Bone marrow mesenchymal stem cell-derived exosomes attenuate the maturation of dendritic cells and reduce the rejection of allogeneic skin transplantation in mice model

[The Effect of Co-Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells and Islet on Maturation and Function of Bone Marrow-Derived Dendritic Cells in Recipient Mice].

Mesenchymal stem cells suppress CD8+ T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β

Effect of mesenchymal stem cell-derived exosomes on the induction of mouse tolerogenic dendritic cells

Mesenchymal Stem Cells Induce Mature Dendritic Cells into A Novel Jagged-2-Dependent Regulatory Dendritic Cell Population

Mesenchymal stem cell therapy induces FLT3L and CD1c + dendritic cells in systemic lupus erythematosus patients

Immune Tolerance of Allogeneic T Cells Induced by Dendritic Cells Genetically Engineered to Express Iκ Bα Mutant

Immunosuppressive Effects of Rat Mesenchymal Stem Cells: Involvement of CD4+CD25+ Regulatory T Cells.

Mesenchymal Stem Cells Tune the Development of Monocyte-Derived Dendritic Cells Toward a Myeloid-Derived Suppressive Phenotype through Growth-Regulated Oncogene Chemokines

Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6

Discrimination of the Heterogeneity of Bone Marrow-Derived Dendritic Cells

Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells.

TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression

The potential of mesenchymal stem cells to induce immune tolerance to allogeneic transplants

Contrariety of Human Bone Marrow Mesenchymal Stromal Cell Functionality in Modulating Circulatory Myeloid and Plasmacytoid Dendritic Cell Subsets

Effect of Allogenic Bone Marrow Mesenchymal Stem Cell Transplantation on T Cells of Old Mice

The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-β1 related pathway